Advisors Capital Management LLC Acquires 8,745 Shares of Bruker Corporation $BRKR

Key Points

• Advisors Capital Management LLC increased its shares in Bruker Corporation by 12% during Q1, totaling 81,425 shares valued at approximately $3.4 million.
• Bruker Corporation reported Q2 earnings per share of $0.32, missing estimates by $0.01, with a revenue of $797.4 million, representing a slight decline compared to the previous year.
• The company announced a quarterly dividend of $0.05 per share, set to be paid on October 3rd, with a current dividend yield of 0.6%.

Advisors Capital Management LLC raised its stake in Bruker Corporation (NASDAQ:BRKR - Free Report) by 12.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 81,425 shares of the medical research company's stock after buying an additional 8,745 shares during the period. Advisors Capital Management LLC owned about 0.05% of Bruker worth $3,399,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Teacher Retirement System of Texas increased its holdings in shares of Bruker by 5.1% in the 1st quarter. Teacher Retirement System of Texas now owns 29,045 shares of the medical research company's stock worth $1,212,000 after buying an additional 1,422 shares during the last quarter. Fifth Third Bancorp grew its holdings in shares of Bruker by 54.2% during the 1st quarter. Fifth Third Bancorp now owns 1,109 shares of the medical research company's stock valued at $46,000 after purchasing an additional 390 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its holdings in shares of Bruker by 81.2% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 29,826 shares of the medical research company's stock valued at $1,245,000 after purchasing an additional 13,367 shares during the last quarter. OneDigital Investment Advisors LLC grew its holdings in shares of Bruker by 38.0% during the 1st quarter. OneDigital Investment Advisors LLC now owns 5,522 shares of the medical research company's stock valued at $230,000 after purchasing an additional 1,520 shares during the last quarter. Finally, Amundi grew its holdings in Bruker by 373.3% in the 1st quarter. Amundi now owns 42,503 shares of the medical research company's stock worth $1,774,000 after acquiring an additional 33,522 shares during the last quarter. Institutional investors own 79.52% of the company's stock.

Insider Activity at Bruker

In other news, Director Cynthia M. Friend sold 3,535 shares of Bruker stock in a transaction that occurred on Friday, September 12th. The shares were sold at an average price of $32.25, for a total value of $114,003.75. Following the completion of the sale, the director directly owned 18,016 shares in the company, valued at $581,016. The trade was a 16.40% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 27.30% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

BRKR has been the topic of a number of recent analyst reports. Bank of America cut their price target on shares of Bruker from $61.00 to $50.00 and set a "buy" rating on the stock in a report on Thursday, June 26th. Citigroup dropped their target price on shares of Bruker from $40.00 to $38.00 and set a "neutral" rating for the company in a research report on Monday, August 4th. Wells Fargo & Company dropped their target price on shares of Bruker from $60.00 to $50.00 and set an "overweight" rating for the company in a research report on Tuesday, August 5th. Stifel Nicolaus set a $40.00 price target on shares of Bruker and gave the company a "hold" rating in a research report on Tuesday, August 5th. Finally, Jefferies Financial Group set a $60.00 price target on shares of Bruker and gave the company a "buy" rating in a research report on Monday, August 4th. Five research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, Bruker has an average rating of "Hold" and an average target price of $51.30.

Bruker Stock Up 4.3%

Bruker stock traded up $1.38 during trading hours on Thursday, hitting $33.49. The stock had a trading volume of 1,244,491 shares, compared to its average volume of 2,702,120. The company has a quick ratio of 0.70, a current ratio of 1.61 and a debt-to-equity ratio of 1.31. The stock has a market capitalization of $5.08 billion, a P/E ratio of 64.61, a price-to-earnings-growth ratio of 4.62 and a beta of 1.21. Bruker Corporation has a 12-month low of $28.53 and a 12-month high of $72.94. The stock's 50-day moving average price is $35.45 and its 200-day moving average price is $38.64.

Bruker (NASDAQ:BRKR - Get Free Report) last issued its earnings results on Monday, August 4th. The medical research company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.33 by ($0.01). Bruker had a return on equity of 17.89% and a net margin of 2.31%.The firm had revenue of $797.40 million during the quarter, compared to analysts' expectations of $811.17 million. During the same period last year, the firm posted $0.52 earnings per share. The firm's quarterly revenue was down .4% on a year-over-year basis. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. Equities research analysts anticipate that Bruker Corporation will post 2.69 EPS for the current fiscal year.

Bruker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 3rd. Stockholders of record on Tuesday, September 23rd will be paid a $0.05 dividend. The ex-dividend date is Tuesday, September 23rd. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.6%. Bruker's payout ratio is currently 38.46%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.